Trump gets tariffs; Americans get price hikes

AI's impact on entry-level jobs is a mixed bag—while job postings are down and youth unemployment is rising, some research hints that AI could actually open doors in certain industries. It’s not all doom and gloom, but it’s not a clear win either.

Editor’s Note: This isn’t just another "robots are stealing jobs" headline. The real story is more nuanced: AI might be reshaping who gets hired and for what, rather than just eliminating roles outright. For young workers and recent grads, that could mean fewer traditional starter jobs but new (and possibly unexpected) opportunities. Worth keeping an eye on.

KKR, the heavyweight investment firm, is doubling down on healthcare by snapping up a majority stake in HealthCare Royalty Partners—a company that profits from drug royalties. Think of it like buying a slice of future revenue from blockbuster medications without having to develop them.

Editor’s Note: This isn’t just another corporate deal—it’s a sign that big money sees healthcare, especially pharmaceuticals, as a safe bet for steady returns. KKR’s move could mean more investment flowing into drug development, but it also raises questions about whether financial firms should have this much influence over an industry that affects people’s health. Either way, it’s a reminder that healthcare isn’t just about doctors and hospitals—it’s big business.

Investors are keeping a close eye on the Federal Reserve's meeting today, with S&P 500 futures ticking up slightly as earnings reports from companies like Hershey roll in. The market is balancing optimism from corporate performance with anticipation over the Fed's interest rate decision—will they hold steady or signal future cuts?

Editor’s Note: This isn’t just another Fed meeting—it’s a pulse check for the economy. Strong earnings could buoy stocks, but the real story hinges on whether the Fed hints at easing rates later this year or stays cautious. For everyday investors, it’s a reminder that markets hang on every word from policymakers.

This article dives into the financial and operational challenges businesses face when trying to maintain workplace safety standards. It explores everything from PPE costs to training expenses, and whether companies—especially small ones—can afford to keep up.

Editor’s Note: Workplace safety isn’t just about rules—it’s about real-world costs. With rising expenses and tighter budgets, businesses are weighing how much they can realistically invest in protecting employees. This matters because if safety measures become too expensive to implement, workers could be at risk, and companies might face legal or reputational fallout. It’s a tough balancing act.

Back in 1985, NASA found itself in the middle of an unexpected space-age showdown—not over science or politics, but soda. The Reagan White House and a crew of astronauts got pulled into a zero-gravity marketing stunt as Coca-Cola and Pepsi battled to be the first cola consumed in orbit. It was a quirky moment where space exploration collided with corporate rivalry, proving even astronauts aren’t immune to Earth’s silliest competitions.

Editor’s Note: This story isn’t just about fizzy drinks—it’s a fun reminder of how pop culture and capitalism have always had a way of sneaking into even the most serious endeavors. It also highlights NASA’s occasional role as an unwitting player in corporate PR wars, showing that space missions aren’t just about flags and footprints. Who knew the "Cola Wars" could reach literal new heights?